Removing Lab Players From the Chessboard
IN 1997-98, CEO Ken Freeman of Quest Diagnostics Incorporated made a keen insight about the commercial lab marketplace. At that time the three blood brothers—Laboratory Corporation of America, Quest Diagnostics, and SmithKline Beecham Clinical Laboratories (SBCL)—dominated the national market for physicians’ office testing. Freeman’s observation would be prophetic. He noted that, in any industry dominated …
Removing Lab Players From the Chessboard Read More »